Mannose 6-phosphate-dependent targeting of lysosomal enzymes is required for normal craniofacial and dental development. 2016

Till Koehne, and Sandra Markmann, and Michaela Schweizer, and Nicole Muschol, and Reinhard E Friedrich, and Christian Hagel, and Markus Glatzel, and Bärbel Kahl-Nieke, and Michael Amling, and Thorsten Schinke, and Thomas Braulke
Department of Orthodontics, University Medical Center Hamburg-Eppendorf, 20246 Hamburg, Germany; Department of Osteology, University Medical Center Hamburg-Eppendorf, 20246 Hamburg, Germany.

Mucolipidosis II (MLII) is a severe systemic genetic disorder caused by defects in mannose 6-phosphate-dependent targeting of multiple lysosomal hydrolases and subsequent lysosomal accumulation of non-degraded material. MLII patients exhibit marked facial coarseness and gingival overgrowth soon after birth, accompanied with delayed tooth eruption and dental infections. To examine the pathomechanisms of early craniofacial and dental abnormalities, we analyzed mice with an MLII patient mutation that mimic the clinical and biochemical symptoms of MLII patients. The mouse data were compared with clinical and histological data of gingiva and teeth from MLII patients. Here, we report that progressive thickening and porosity of calvarial and mandibular bones, accompanied by elevated bone loss due to 2-fold higher number of osteoclasts cause the characteristic craniofacial phenotype in MLII. The analysis of postnatal tooth development by microcomputed tomography imaging and histology revealed normal dentin and enamel formation, and increased cementum thickness accompanied with accumulation of storage material in cementoblasts of MLII mice. Massive accumulation of storage material in subepithelial cells as well as disorganization of collagen fibrils led to gingival hypertrophy. Electron and immunofluorescence microscopy, together with (35)S-sulfate incorporation experiments revealed the accumulation of non-degraded material, non-esterified cholesterol and glycosaminoglycans in gingival fibroblasts, which was accompanied by missorting of various lysosomal proteins (α-fucosidase 1, cathepsin L and Z, Npc2, α-l-iduronidase). Our study shows that MLII mice closely mimic the craniofacial and dental phenotype of MLII patients and reveals the critical role of mannose 6-phosphate-dependent targeting of lysosomal proteins for alveolar bone, cementum and gingiva homeostasis.

UI MeSH Term Description Entries
D007223 Infant A child between 1 and 23 months of age. Infants
D008247 Lysosomes A class of morphologically heterogeneous cytoplasmic particles in animal and plant tissues characterized by their content of hydrolytic enzymes and the structure-linked latency of these enzymes. The intracellular functions of lysosomes depend on their lytic potential. The single unit membrane of the lysosome acts as a barrier between the enzymes enclosed in the lysosome and the external substrate. The activity of the enzymes contained in lysosomes is limited or nil unless the vesicle in which they are enclosed is ruptured or undergoes MEMBRANE FUSION. (From Rieger et al., Glossary of Genetics: Classical and Molecular, 5th ed). Autolysosome,Autolysosomes,Lysosome
D008297 Male Males
D008360 Mannosephosphates Phosphoric acid esters of mannose.
D008810 Mice, Inbred C57BL One of the first INBRED MOUSE STRAINS to be sequenced. This strain is commonly used as genetic background for transgenic mouse models. Refractory to many tumors, this strain is also preferred model for studying role of genetic variations in development of diseases. Mice, C57BL,Mouse, C57BL,Mouse, Inbred C57BL,C57BL Mice,C57BL Mice, Inbred,C57BL Mouse,C57BL Mouse, Inbred,Inbred C57BL Mice,Inbred C57BL Mouse
D008817 Mice, Mutant Strains Mice bearing mutant genes which are phenotypically expressed in the animals. Mouse, Mutant Strain,Mutant Mouse Strain,Mutant Strain of Mouse,Mutant Strains of Mice,Mice Mutant Strain,Mice Mutant Strains,Mouse Mutant Strain,Mouse Mutant Strains,Mouse Strain, Mutant,Mouse Strains, Mutant,Mutant Mouse Strains,Mutant Strain Mouse,Mutant Strains Mice,Strain Mouse, Mutant,Strain, Mutant Mouse,Strains Mice, Mutant,Strains, Mutant Mouse
D009081 Mucolipidoses A group of inherited metabolic diseases characterized by the accumulation of excessive amounts of acid mucopolysaccharides, sphingolipids, and/or glycolipids in visceral and mesenchymal cells. Abnormal amounts of sphingolipids or glycolipids are present in neural tissue. INTELLECTUAL DISABILITY and skeletal changes, most notably dysostosis multiplex, occur frequently. (From Joynt, Clinical Neurology, 1992, Ch56, pp36-7) Cherry Red Spot Myoclonus Syndrome,Ganglioside Sialidase Deficiency Disease,I-Cell Disease,Lipomucopolysaccharidosis,Mucolipidosis,Myoclonus Cherry Red Spot Syndrome,Pseudo-Hurler Polydystrophy,Sialidosis,Cherry Red Spot-Myoclonus Syndrome,Deficiency Disease, Ganglioside Sialidase,Glycoprotein Neuraminidase Deficiency,Inclusion Cell Disease,Mucolipidosis I,Mucolipidosis II,Mucolipidosis III,Mucolipidosis III Alpha Beta,Mucolipidosis IIIa,Mucolipidosis IV,Mucolipidosis Type 1,Mucolipidosis Type I,Mucolipidosis Type II,Mucolipidosis Type III,Mucolipidosis Type IV,Myoclonus-Cherry Red Spot Syndrome,Psuedo-Hurler Disease,Sialolipidosis,Type I Mucolipidosis,Type II Mucolipidosis,Type III Mucolipidosis,Type IV Mucolipidosis,Deficiencies, Glycoprotein Neuraminidase,Deficiency, Glycoprotein Neuraminidase,Glycoprotein Neuraminidase Deficiencies,I Cell Disease,I-Cell Diseases,Inclusion Cell Diseases,Lipomucopolysaccharidoses,Mucolipidoses, Type I,Mucolipidoses, Type II,Mucolipidoses, Type III,Mucolipidoses, Type IV,Mucolipidosis, Type I,Mucolipidosis, Type II,Mucolipidosis, Type III,Mucolipidosis, Type IV,Polydystrophy, Pseudo-Hurler,Pseudo Hurler Polydystrophy,Psuedo Hurler Disease,Psuedo-Hurler Diseases,Sialidoses,Sialolipidoses,Type I Mucolipidoses,Type II Mucolipidoses,Type III Mucolipidoses,Type IV Mucolipidoses
D009805 Odontogenesis The process of TOOTH formation. It is divided into several stages including: the dental lamina stage, the bud stage, the cap stage, and the bell stage. Odontogenesis includes the production of tooth enamel (AMELOGENESIS), dentin (DENTINOGENESIS), and dental cementum (CEMENTOGENESIS). Odontogeneses
D001846 Bone Development The growth and development of bones from fetus to adult. It includes two principal mechanisms of bone growth: growth in length of long bones at the epiphyseal cartilages and growth in thickness by depositing new bone (OSTEOGENESIS) with the actions of OSTEOBLASTS and OSTEOCLASTS. Bone Growth
D002648 Child A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL. Children

Related Publications

Till Koehne, and Sandra Markmann, and Michaela Schweizer, and Nicole Muschol, and Reinhard E Friedrich, and Christian Hagel, and Markus Glatzel, and Bärbel Kahl-Nieke, and Michael Amling, and Thorsten Schinke, and Thomas Braulke
November 1990, The EMBO journal,
Till Koehne, and Sandra Markmann, and Michaela Schweizer, and Nicole Muschol, and Reinhard E Friedrich, and Christian Hagel, and Markus Glatzel, and Bärbel Kahl-Nieke, and Michael Amling, and Thorsten Schinke, and Thomas Braulke
December 1991, Cell biology international reports,
Till Koehne, and Sandra Markmann, and Michaela Schweizer, and Nicole Muschol, and Reinhard E Friedrich, and Christian Hagel, and Markus Glatzel, and Bärbel Kahl-Nieke, and Michael Amling, and Thorsten Schinke, and Thomas Braulke
July 1989, The Journal of biological chemistry,
Till Koehne, and Sandra Markmann, and Michaela Schweizer, and Nicole Muschol, and Reinhard E Friedrich, and Christian Hagel, and Markus Glatzel, and Bärbel Kahl-Nieke, and Michael Amling, and Thorsten Schinke, and Thomas Braulke
August 1996, The Journal of cell biology,
Till Koehne, and Sandra Markmann, and Michaela Schweizer, and Nicole Muschol, and Reinhard E Friedrich, and Christian Hagel, and Markus Glatzel, and Bärbel Kahl-Nieke, and Michael Amling, and Thorsten Schinke, and Thomas Braulke
January 2009, Biological chemistry,
Till Koehne, and Sandra Markmann, and Michaela Schweizer, and Nicole Muschol, and Reinhard E Friedrich, and Christian Hagel, and Markus Glatzel, and Bärbel Kahl-Nieke, and Michael Amling, and Thorsten Schinke, and Thomas Braulke
December 2008, Biochemical and biophysical research communications,
Till Koehne, and Sandra Markmann, and Michaela Schweizer, and Nicole Muschol, and Reinhard E Friedrich, and Christian Hagel, and Markus Glatzel, and Bärbel Kahl-Nieke, and Michael Amling, and Thorsten Schinke, and Thomas Braulke
September 1987, The EMBO journal,
Till Koehne, and Sandra Markmann, and Michaela Schweizer, and Nicole Muschol, and Reinhard E Friedrich, and Christian Hagel, and Markus Glatzel, and Bärbel Kahl-Nieke, and Michael Amling, and Thorsten Schinke, and Thomas Braulke
October 1993, The Journal of cell biology,
Till Koehne, and Sandra Markmann, and Michaela Schweizer, and Nicole Muschol, and Reinhard E Friedrich, and Christian Hagel, and Markus Glatzel, and Bärbel Kahl-Nieke, and Michael Amling, and Thorsten Schinke, and Thomas Braulke
March 1991, European journal of clinical chemistry and clinical biochemistry : journal of the Forum of European Clinical Chemistry Societies,
Till Koehne, and Sandra Markmann, and Michaela Schweizer, and Nicole Muschol, and Reinhard E Friedrich, and Christian Hagel, and Markus Glatzel, and Bärbel Kahl-Nieke, and Michael Amling, and Thorsten Schinke, and Thomas Braulke
February 1984, Cell,
Copied contents to your clipboard!